Literature DB >> 7772526

Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients.

P D Jensen1, F T Jensen, T Christensen, J Ellegaard.   

Abstract

The ability to quantitate transfusional iron overload is crucial for determining the need for and the efficacy of chelation therapy in patients with long-standing transfusion-dependent anaemias. We evaluated the usefulness of some indirect measures of iron overload in estimating the iron concentration in the liver--the most important iron storage organ--in 26 non-chelated adult non-thalassaemic patients. Liver iron concentration was determined non-invasively by magnetic resonance imaging (MRI). The standard error of the estimated liver iron concentration was 80 mumol Fe/g dried liver tissue when using the number of transfused blood units, and 93 mumol Fe/g when using a serum ferritin assay. Follow-up in 11 patients (12-48 months) revealed that serum ferritin is a poor measure of the liver iron concentration during iron chelation. However, this discrepancy was individually different and seemed to be dependent on the erythropoietic marrow activity. By monitoring the liver iron concentration by MRI, we compared the efficacy of chelation with desferrioxamine given either by subcutaneous continuous infusions or by bolus injections. Depletion of liver iron stores could be achieved efficiently by both regimens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772526     DOI: 10.1111/j.1365-2141.1995.tb08428.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

Review 2.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients.

Authors:  Natalia Maximova; Giulia Caddeo; Davide Zanon; Alessandra Maestro; Roberto Simeone
Journal:  J Clin Med       Date:  2019-06-10       Impact factor: 4.241

4.  Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

Authors:  Philip Hilgard; Guido Gerken
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 5.  Iron overload in patients with myelodysplastic syndromes.

Authors:  Peter-D Jensen
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 4.213

6.  Biopsy-based optimization and calibration of a signal-intensity-ratio-based MRI method (1.5 Tesla) in a dextran-iron loaded mini-pig model, enabling estimation of very high liver iron concentrations.

Authors:  Peter D Jensen; Asbjørn H Nielsen; Carsten W Simonsen; Kenneth K Jensen; Martin Bøgsted; Anne B H Jensen; Benedict Kjaergaard
Journal:  MAGMA       Date:  2022-01-17       Impact factor: 2.533

7.  Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review.

Authors:  J Caro; Krista F Huybrechts; Traci C Green
Journal:  BMC Blood Disord       Date:  2002-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.